Adamas Pharma (ADMS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ADMS | GBIO | CBAY | ||
| Company | Adamas Pharma | Generation Bio CO | Cymabay Therapeutics | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 8.24 | 6.44 | 2.77 | ||
| High | 8.25 | 6.72 | 2.92 | ||
| Low | 8.18 | 6.32 | 2.72 | ||
| Last | 8.22 | 6.60 | 2.94 | ||
| Change | +0.06 | -0.02 | +0.09 | ||
| % Change | +0.74% | -0.30% | +3.16% | ||
| Volume | 3,151,400 | 139,446 | 292,560 | ||
| 20-Day Average Volume | 834,440 | 463,046 | 1,174,390 | ||
| Previous Close | 8.16 | 6.62 | 2.85 | ||
| Industry | Medical - Generic Drugs | Medical - Generic Drugs | Medical - Generic Drugs | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 8.16 | 6.15 | 2.33 | ||
| 20-Day Raw Stochastic | 86.36% | 50.51% | 88.31% | ||
| 20-Day Relative Strength | 73.46% | 53.36% | 64.25% | ||
| Weighted Alpha | +22.54 | -54.04 | -44.64 | ||
| Today's Opinion | 100% Buy | 8% Sell | 8% Sell | ||
| Previous Opinion | 96% Buy | 8% Sell | 24% Sell | ||
| Last Month's Opinion | 100% Buy | 88% Sell | 88% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.86% since 11/16/21 | -6.91% since 06/23/22 | +12.16% since 06/23/22 | ||
| Low | 8.15 on 11/17/21 | 6.18 on 06/29/22 | 2.33 on 06/24/22 | ||
| High | 8.25 on 11/23/21 | 8.00 on 06/27/22 | 3.05 on 06/27/22 | ||
| 1-Month | |||||
| %Chg | +2.62% since 10/22/21 | +20.57% since 05/27/22 | +43.10% since 05/27/22 | ||
| Low | 8.00 on 10/25/21 | 5.04 on 06/02/22 | 1.81 on 06/16/22 | ||
| High | 8.25 on 11/23/21 | 8.00 on 06/27/22 | 3.05 on 06/27/22 | ||
| 3-Month | |||||
| %Chg | +77.54% since 08/23/21 | -9.11% since 03/30/22 | -6.59% since 03/30/22 | ||
| Low | 4.41 on 08/27/21 | 4.68 on 05/24/22 | 1.67 on 05/11/22 | ||
| High | 8.25 on 11/23/21 | 9.59 on 04/13/22 | 3.47 on 04/04/22 | ||
| 6-Month | |||||
| %Chg | +57.47% since 05/21/21 | -8.35% since 12/30/21 | -11.97% since 12/30/21 | ||
| Low | 4.02 on 08/16/21 | 3.96 on 02/24/22 | 1.67 on 05/11/22 | ||
| High | 8.25 on 11/23/21 | 9.59 on 04/13/22 | 3.65 on 01/04/22 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 376,369 | 377,923 | 241,332 | ||
| Shares Outstanding, K | 45,787 | 57,088 | 84,678 | ||
| Annual Sales | 74,460,000 | 0 | 0 | ||
| Annual Net Income | -57,400,000 | -119,150,000 | -90,000,000 | ||
| Last Quarter Sales | 25,900,000 | 0 | 0 | ||
| Last Quarter Net Income | -19,520,000 | -35,000,000 | -27,770,000 | ||
| 60-Month Beta | 2.82 | 2.87 | 1.09 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A on 11/10/21 | -0.61 on 05/05/22 | -0.32 on 05/12/22 | ||
| Latest Earnings Date | 11/11/21 | 08/10/22 | 08/11/22 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||
